A new vaccine targeting triple-negative breast cancer (TNBC), one of the most hard-to-treat types, has shown early promise in ...

The 5 most-read breast cancer articles on AJMC.com this year included FDA approvals, emerging therapies for metastatic breast ...

A recent breast cancer vaccine brings good news for women. The jab could help prevent Triple-negative breast cancer (TNBC) ...

An experimental vaccine targeting aggressive triple-negative breast cancer (TNBC) has shown encouraging early results in clinical trials. The vaccine ...

Global interim Phase 2 data in locally advanced/metastatic triple-negative breast cancer (”TNBC”) show encouraging antitumor activity for investigational therapy pumitamig (BNT327/BMS986545) plus ...

A novel vaccine targeting triple-negative breast cancer (TNBC), one of the most aggressive and hard-to-treat forms, has shown ...

Blood tests detecting circulating tumour DNA could help guide treatment for triple negative breast cancer patientsAbsence of ...

The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for DATROWAY ® (datopotamab deruxtecan) as monotherapy for the first-line treatment of adult ...

Eric H. Yang, MD, warns that lifetime cardiovascular risk for patients with breast cancer may exceed the general population as life expectancies grow, emphasizing the need for early intervention.

BioNTech and Bristol Myers Squibb share positive data from Phase 2 trial of pumitamig plus chemotherapy for triple-negative ...

Leronlimab treatment is associated with upregulation of PD-L1 in circulating tumor cells and cancer-associated macrophage-like cells Remarkably longer survival was observed in patients treated with ...

CytoDyn (CYDY) announced that breast cancer specialist and medical oncologist, Milana V. Dolezal, MD, MSci, is presenting a ...